NCT07173699

Brief Summary

This clinical study aims to evaluate the effect of salivary melatonin levels on postoperative pain and sleep quality in patients undergoing root canal treatment at different times of the day. Each participant will receive endodontic treatment on two asymptomatic mandibular molars, one in the morning and the other in the afternoon. Pain intensity and sleep quality will be assessed using standard questionnaires, and salivary melatonin levels will be analyzed.

Trial Health

75
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
45

participants targeted

Target at P25-P50 for not_applicable

Timeline
2mo left

Started Sep 2025

Geographic Reach
1 country

1 active site

Status
active not recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress82%
Sep 2025Jul 2026

Study Start

First participant enrolled

September 1, 2025

Completed
7 days until next milestone

First Submitted

Initial submission to the registry

September 8, 2025

Completed
7 days until next milestone

First Posted

Study publicly available on registry

September 15, 2025

Completed
7 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 20, 2026

Completed
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

July 20, 2026

Expected
Last Updated

September 15, 2025

Status Verified

August 1, 2025

Enrollment Period

8 months

First QC Date

September 8, 2025

Last Update Submit

September 8, 2025

Conditions

Keywords

Root Canal Treatment; Salivary Melatonin; Circadian Rhythm; Postoperative Pain; Sleep Quality

Outcome Measures

Primary Outcomes (1)

  • Postoperative pain intensity

    Pain intensity will be assessed using a 10-cm Visual Analogue Scale (VAS), where 0 represents "no pain" and 10 represents "worst pain imaginable." Participants will record their pain levels following root canal treatment sessions performed in the morning and afternoon.

    Within 7 days after each root canal treatment session

Secondary Outcomes (1)

  • Sleep quality

    Within 7 days after each root canal treatment session

Study Arms (2)

Arm 1: Morning Arm

EXPERIMENTAL

Root canal treatment performed on an asymptomatic mandibular molar in the morning session (08:30-09:30). Standard endodontic protocol will be applied. Saliva samples will be collected before the procedure for melatonin analysis, and postoperative pain and sleep quality will be assessed.

Procedure: root canal treatment

Arm 2: Afternoon Arm

EXPERIMENTAL

Root canal treatment performed on an asymptomatic mandibular molar in the afternoon session (14:00-15:00). Standard endodontic protocol will be applied. Saliva samples will be collected before the procedure for melatonin analysis, and postoperative pain and sleep quality will be assessed.

Procedure: root canal treatment

Interventions

Standardized root canal treatment performed on asymptomatic mandibular molars. Procedures include local anesthesia, rubber dam isolation, access cavity preparation, cleaning and shaping with rotary instruments, irrigation with NaOCl and EDTA, and obturation using a standardized protocol. Saliva samples are collected prior to treatment for melatonin analysis. Postoperative pain and sleep quality are assessed using validated questionnaires.

Arm 1: Morning ArmArm 2: Afternoon Arm

Eligibility Criteria

Age25 Years - 45 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • Patients aged 25-45 years Patients with two asymptomatic, devital mandibular molars in the same arch No radiographic evidence of periapical lesions or pathological formations in the teeth Patients without systemic diseases (ASA I) Patients who have not used antibiotics, analgesics, or melatonin-containing medications within the last week Patients who have signed the informed consent form

You may not qualify if:

  • Patients with a diagnosis of sleep disorder or those regularly using sleep medications/sedatives Patients with systemic diseases (e.g., hypertension, diabetes, endocrine disorders, etc.) Patients receiving psychiatric treatment Pregnant or breastfeeding patients Patients unable to cooperate during the treatment process Patients with restorative or periodontal complications in their teeth Patients working in a shift system

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Atatürk University Faculty of Dentistry, Department of Endodontics

Erzurum, 25240, Turkey (Türkiye)

Location

Related Publications (2)

  • Benloucif S, Burgess HJ, Klerman EB, Lewy AJ, Middleton B, Murphy PJ, Parry BL, Revell VL. Measuring melatonin in humans. J Clin Sleep Med. 2008 Feb 15;4(1):66-9.

    PMID: 18350967BACKGROUND
  • Segura-Egea JJ, Cisneros-Cabello R, Llamas-Carreras JM, Velasco-Ortega E. Pain associated with root canal treatment. Int Endod J. 2009 Jul;42(7):614-20. doi: 10.1111/j.1365-2591.2009.01562.x. Epub 2009 May 8.

    PMID: 19467050BACKGROUND

MeSH Terms

Conditions

Pain, PostoperativeSleep Initiation and Maintenance Disorders

Condition Hierarchy (Ancestors)

Postoperative ComplicationsPathologic ProcessesPathological Conditions, Signs and SymptomsPainNeurologic ManifestationsSigns and SymptomsSleep Disorders, IntrinsicDyssomniasSleep Wake DisordersNervous System DiseasesMental Disorders

Study Officials

  • KEZBAN MELTEM COLAK, PROF.

    Atatürk University, Faculty of Dentistry, Department of Endodontics

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
NONE
Masking Details
This is an open-label study; both participants and investigators are aware of the timing of the intervention.
Purpose
BASIC SCIENCE
Intervention Model
CROSSOVER
Model Details: Split-mouth crossover design: Each participant will receive root canal treatment on two asymptomatic mandibular molars, one in the morning session and the other in the afternoon session, with a one-week interval.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
KEZBAN MELTEM COLAK

Study Record Dates

First Submitted

September 8, 2025

First Posted

September 15, 2025

Study Start

September 1, 2025

Primary Completion

April 20, 2026

Study Completion (Estimated)

July 20, 2026

Last Updated

September 15, 2025

Record last verified: 2025-08

Data Sharing

IPD Sharing
Will not share

Individual participant data (IPD) will not be shared because this is a single-center academic thesis study with a limited number of patients. Data include personal health information, and sharing outside the study team is restricted due to ethical and confidentiality considerations.

Locations